Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
This study has been completed.
Sponsor:
Veeda Oncology
Collaborator:
Bristol-Myers Squibb
Information provided by:
Veeda Oncology
ClinicalTrials.gov Identifier:
NCT00251498
First received: November 8, 2005
Last updated: August 20, 2008
Last verified: August 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2007 |
| Estimated Primary Completion Date: | No date given |